NEU 0.00% $19.86 neuren pharmaceuticals limited

Share Price, page-7851

  1. 118 Posts.
    lightbulb Created with Sketch. 16
    If we get to a high of 22 prior to readout and results turn out negative, I do see recent buyers (who bought at a premium) as eager to sell. There may be other loose hands who get caught by the red sentiment, so that the shareprice falls back down to 10. I also wouldn't blame long term holders for taking a bit of profit.

    that said, the next sales and royalty update should level it back up to the levels we were stuck on for ages - 11, 12 or 13 dollars.

    It will test the patience of long term holders, and i agree with baldwidx that we could infer negative results in 1 could lead to negative results in any of the other trials.

    what are the chances of all 4 trials being negative though? Unlikely I think, after everything we've heard about 2591 being the superior chemical compound...

    those who believe and hold on will be the ones that see a profit when the tide turns.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.